Allogeneic adipose tissue-derived mesenchymal stem cells in ischaemic stroke (AMASCIS-02): a phase IIb, multicentre, double-blind, placebo-controlled clinical trial protocol

INTRODUCTION: Stroke is a serious public health problem, given it is a major cause of disability worldwide despite the spread of recanalisation therapies. Enhancement of brain plasticity with stem cell administration is a promising innovative therapy to reduce sequelae in these patients. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: de Celis-Ruiz, Elena, Fuentes, Blanca, Moniche, Francisco, Montaner, Joan, Borobia, Alberto M, Gutiérrez-Fernández, Maria, Díez-Tejedor, Exuperio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354278/
https://www.ncbi.nlm.nih.gov/pubmed/34373315
http://dx.doi.org/10.1136/bmjopen-2021-051790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354278/
https://www.ncbi.nlm.nih.gov/pubmed/34373315
http://dx.doi.org/10.1136/bmjopen-2021-051790

Ejemplares similares